Company Overview - Surrozen, Inc. is a clinical stage biotechnology company focused on discovering and developing drug candidates that selectively modulate the Wnt pathway for tissue repair and regeneration [2] - The company is currently concentrating on developing tissue-specific antibodies aimed at treating severe liver and eye diseases [2] Upcoming Events - Craig Parker, President and CEO of Surrozen, will present at two healthcare investor conferences: - Guggenheim's Inaugural Healthcare Innovation Conference on November 13, 2024, at 3:00 PM ET [1] - Stifel 2024 Healthcare Conference on November 19, 2024, at 2:25 PM ET [1] - Live audio webcasts for these conferences will be accessible via the Investors section of the Surrozen website, with replays archived afterward [1]
Surrozen to Present at Upcoming Healthcare Investor Conferences